JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5526
PUT
Archer Daniels Midland
ADM
$39.7B
| $40K | ﹤0.01% |
+500
| New | +$40.8K |
2023 Q1
0 quarters
|
|
5527
PUT
First Majestic Silver
AG
$8.63B
| $40K | ﹤0.01% |
5,600
-300
| -5% | -$2.21K |
2022 Q3
2 quarters
|
|
5528
Invesco S&P Global Water Index ETF
CGW
$1.03B
| $40K | ﹤0.01% |
800
-1,557
| -66% | -$76.4K |
2022 Q4
1 quarter
|
|
5529
Local Bounti
LOCL
$25.3M
| $40K | ﹤0.01% |
3,821
+1,007
| +36% | +$10.8K |
2022 Q1
4 quarters
|
|
5530
POET Technologies
POET
$1.35B
| $40K | ﹤0.01% |
+4,100
| New | +$17.7K |
2023 Q1
0 quarters
|
|
5531
Summit Therapeutics
SMMT
$13.8B
| $40K | ﹤0.01% |
23,104
+9,522
| +70% | +$26K |
2020 Q3
10 quarters
|
|
5532
The Beachbody Company
BODI
$35.1M
| $40K | ﹤0.01% |
1,637
+408
| +33% | +$12.6K |
2021 Q3
6 quarters
|
|
5533
Palladyne AI
PDYN
$253M
| $40K | ﹤0.01% |
13,993
+934
| +7% | +$3.26K |
2021 Q3
6 quarters
|
|
|
AMRN
5534
Amarin Corp
AMRN
$255M
| $39.6K | ﹤0.01% |
1,321
-308
| -19% | -$10.8K |
2016 Q3
26 quarters
|
|
5535
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$5.89B
| $39.5K | ﹤0.01% |
1,277
+172
| +16% | +$5.23K |
2019 Q3
14 quarters
|
|
5536
BlackRock Municipal 2030 Target Term Trust
BTT
$1.38B
| $39.2K | ﹤0.01% |
1,826
+170
| +10% | +$3.68K |
2022 Q3
2 quarters
|
|
|
5537
CALL
First Majestic Silver
AG
$8.63B
| $39K | ﹤0.01% |
5,400
| – | – |
2022 Q4
1 quarter
|
|
|
5538
First Majestic Silver
AG
$8.63B
| $39K | ﹤0.01% |
5,352
+1,084
| +25% | +$7.98K |
2021 Q4
5 quarters
|
|
5539
iShares MSCI Philippines ETF
EPHE
$136M
| $39K | ﹤0.01% |
+1,452
| New | +$40.1K |
2023 Q1
0 quarters
|
|
|
KORE
5540
DELISTED
KORE Group Holdings
KORE
| $39K | ﹤0.01% |
6,453
+652
| +11% | +$5.51K |
2021 Q4
5 quarters
|
|
5541
NLI Holdings
NL
$343M
| $39K | ﹤0.01% |
6,410
+529
| +9% | +$3.67K |
2016 Q4
25 quarters
|
|
|
OPTN
5542
DELISTED
OptiNose
OPTN
| $39K | ﹤0.01% |
1,358
+304
| +29% | +$8.09K |
2017 Q4
21 quarters
|
|
5543
ProShares Ultra Health Care
RXL
$93.7M
| $39K | ﹤0.01% |
+916
| New | +$40.1K |
2023 Q1
0 quarters
|
|
5544
ProShares UltraShort Financials
SKF
$12.7M
| $39K | ﹤0.01% |
+477
| New | +$35.2K |
2023 Q1
0 quarters
|
|
|
GRIN
5545
DELISTED
Grindrod Shipping Holdings Ltd. Ordinary Shares
GRIN
| $39K | ﹤0.01% |
3,699
-1,242
| -25% | -$17.6K |
2018 Q3
18 quarters
|
|
|
CERE
5546
PUT
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $39K | ﹤0.01% |
+1,600
| New | +$47K |
2023 Q1
0 quarters
|
|
|
EXPR
5547
DELISTED
Express, Inc.
EXPR
| $39K | ﹤0.01% |
2,468
-8,277
| -77% | -$167K |
2021 Q3
6 quarters
|
|
5548
Dimensional US Marketwide Value ETF
DFUV
$15.3B
| $38.5K | ﹤0.01% |
1,149
-26,381
| -96% | -$903K |
2022 Q4
1 quarter
|
|
5549
First Trust Energy AlphaDEX Fund
FXN
$372M
| $38.4K | ﹤0.01% |
2,475
-875
| -26% | -$14.4K |
2020 Q2
11 quarters
|
|
|
HEAL
5550
Global X Funds Global X HealthTech ETF
HEAL
$31.3M
| $38.4K | ﹤0.01% |
1,093
+253
| +30% | +$9.09K |
2022 Q1
4 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.